Protara Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -90 | -93 | -88 | |
EBITDA | -21,596 | -17,692 | -17,214 | -13,170 |
EBIT | -21,668 | -17,782 | -17,307 | -13,258 |
Net Income | -21,668 | -17,782 | -17,307 | -13,258 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,389 | -21,343 | -16,974 | -12,456 |
Cash | 17,076 | 14,737 | 49,657 | 12,551 |
Basic Shares | 61,006 | 57,538 | 46,041 | 42,272 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -362 | -332 | -341 | -247 |
EBITDA | -57,077 | -44,264 | -40,079 | -64,567 |
EBIT | -57,439 | -44,596 | -40,420 | -64,815 |
Net Income | -57,439 | -44,596 | -40,420 | -65,952 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -56,459 | -35,871 | -37,602 | -26,577 |
Cash | 49,657 | 162,798 | 39,586 | 24,127 |
Basic Shares | 42,836 | 20,592 | 11,331 | 11,259 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.36 |
2026-03-31 | -$0.31 |
2025-12-31 | -$0.38 |
2025-09-30 | -$0.31 |